(Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents
US7250440B2 · kind B2 · utility
90Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2004 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | Aug 9, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/88
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides estrogen receptor modulators of formula I, having the structurewhere R1, R2, R3, and R4 are as defined in the specification, or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.